Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel
Open Access
- 15 March 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 182
Abstract
Dissociation of the native transthyretin (TTR) tetramer is widely accepted as the critical step in TTR amyloid fibrillogenesis. It is modelled by exposure of the protein to non-physiological low pH in vitro and is inhibited by small molecule compounds, such as the drug tafamidis. We have recently identified a new mechano-enzymatic pathway of TTR fibrillogenesis in vitro, catalysed by selective proteolytic cleavage, which produces a high yield of genuine amyloid fibrils. This pathway is efficiently inhibited only by ligands that occupy both binding sites in TTR. Tolcapone, which is bound with similar high affinity in both TTR binding sites without the usual negative cooperativity, is therefore of interest. Here we show that TTR fibrillogenesis by the mechano-enzymatic pathway is indeed more potently inhibited by tolcapone than by tafamidis but neither, even in large molar excess, completely prevents amyloid fibril formation. In contrast, mds84, the prototype of our previously reported bivalent ligand TTR ‘superstabiliser’ family, is notably more potent than the monovalent ligands and we show here that this apparently reflects the critical additional interactions of its linker within the TTR central channel. Our findings have major implications for therapeutic approaches in TTR amyloidosis.Keywords
This publication has 21 references indexed in Scilit:
- Novel Antibody for the Treatment of Transthyretin AmyloidosisJournal of Biological Chemistry, 2016
- Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicityNature Communications, 2016
- Uncovering the Mechanism of Aggregation of Human TransthyretinJournal of Biological Chemistry, 2015
- The Amyloidogenic V122I Transthyretin Variant in Elderly Black AmericansNew England Journal of Medicine, 2015
- Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesisProceedings of the National Academy of Sciences, 2014
- Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathyJournal of Neurology, 2013
- Nearly 200 X-Ray Crystal Structures of Transthyretin: What Do They Tell Us About This Protein and the Design of Drugs for TTR Amyloidoses?Current Medicinal Chemistry, 2012
- Calculation of Protein-Ligand Binding AffinitiesAnnual Review of Biophysics, 2007
- Bisaryloxime Ethers as Potent Inhibitors of Transthyretin Amyloid Fibril FormationJournal of Medicinal Chemistry, 2005
- Synthesis and Characterization of Potent Bivalent Amyloidosis Inhibitors That Bind Prior to Transthyretin TetramerizationJournal of the American Chemical Society, 2003